Orthofix Net Working Capital vs Capital Surpluse Analysis
OFIX Stock | USD 15.37 0.24 1.59% |
Orthofix Medical financial indicator trend analysis is much more than just breaking down Orthofix Medical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Orthofix Medical is a good investment. Please check the relationship between Orthofix Medical Net Working Capital and its Capital Surpluse accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orthofix Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.
Net Working Capital vs Capital Surpluse
Net Working Capital vs Capital Surpluse Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Orthofix Medical Net Working Capital account and Capital Surpluse. At this time, the significance of the direction appears to have strong relationship.
The correlation between Orthofix Medical's Net Working Capital and Capital Surpluse is 0.63. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Orthofix Medical, assuming nothing else is changed. The correlation between historical values of Orthofix Medical's Net Working Capital and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of Orthofix Medical are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Net Working Capital i.e., Orthofix Medical's Net Working Capital and Capital Surpluse go up and down completely randomly.
Correlation Coefficient | 0.63 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Net Working Capital
Capital Surpluse
Most indicators from Orthofix Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Orthofix Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orthofix Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.At this time, Orthofix Medical's Issuance Of Capital Stock is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.25 in 2024, whereas Selling General Administrative is likely to drop slightly above 87.6 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 349.6M | 337.2M | 468.9M | 258.6M | Total Revenue | 464.5M | 460.7M | 746.6M | 784.0M |
Orthofix Medical fundamental ratios Correlations
Click cells to compare fundamentals
Orthofix Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Orthofix Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 18.9M | 19.4M | 19.7M | 20.1M | 36.7M | 38.6M | |
Total Assets | 495.6M | 525.9M | 476.6M | 458.6M | 925.3M | 971.6M | |
Other Current Liab | 64.7M | 24.7M | 72.0M | 55.4M | 101.4M | 106.5M | |
Total Current Liabilities | 84.9M | 103.9M | 105.8M | 83.6M | 165.2M | 173.5M | |
Total Stockholder Equity | 327.6M | 356.9M | 336.9M | 336.9M | 598.7M | 628.7M | |
Property Plant And Equipment Net | 62.7M | 63.6M | 59.3M | 58.2M | 178.9M | 187.9M | |
Net Debt | (48.7M) | (71.4M) | (65.4M) | (30.8M) | 96.4M | 101.3M | |
Retained Earnings | 57.7M | 59.4M | 21M | 1.3M | (150.1M) | (142.6M) | |
Accounts Payable | 19.9M | 23.1M | 26.5M | 27.6M | 58.4M | 61.3M | |
Cash | 69.7M | 96.3M | 87.8M | 50.7M | 37.8M | 39.8M | |
Non Current Assets Total | 235.1M | 255.5M | 207.1M | 202.6M | 504.9M | 530.1M | |
Non Currrent Assets Other | 11.9M | 17.3M | 16.7M | 25.7M | 11.1M | 11.7M | |
Cash And Short Term Investments | 69.7M | 96.3M | 87.8M | 50.7M | 37.8M | 39.8M | |
Net Receivables | 86.8M | 72.4M | 78.6M | 82.9M | 128.1M | 79.5M | |
Liabilities And Stockholders Equity | 495.6M | 525.9M | 476.6M | 458.6M | 925.3M | 971.6M | |
Non Current Liabilities Total | 83.1M | 65.1M | 33.9M | 38.1M | 161.4M | 92.9M | |
Inventory | 82.4M | 84.6M | 83.0M | 100.2M | 222.2M | 233.3M | |
Other Current Assets | 20.9M | 16.5M | 20.1M | 22.3M | 32.4M | 20.9M | |
Other Stockholder Equity | 271.0M | 292.3M | 314.0M | 335.0M | 746.5M | 783.8M | |
Total Liab | 168.0M | 169.0M | 139.7M | 121.8M | 326.6M | 165.1M | |
Property Plant And Equipment Gross | 62.7M | 63.6M | 242.2M | 221.2M | 347.7M | 365.1M | |
Total Current Assets | 260.6M | 270.4M | 269.5M | 256.0M | 420.4M | 217.2M | |
Accumulated Other Comprehensive Income | 3.3M | (3.0M) | 3.3M | (1.4M) | (1.3M) | (1.2M) | |
Short Term Debt | 323K | 2.6M | 2.6M | 652K | 5.4M | 4.7M | |
Intangible Assets | 54.1M | 60.5M | 52.7M | 47.4M | 117.5M | 123.4M | |
Common Stock Total Equity | 1.9M | 1.9M | 2.0M | 2.0M | 2.3M | 1.9M | |
Common Stock | 1.9M | 1.9M | 2.0M | 2.0M | 3.7M | 2.0M | |
Other Liab | 58.4M | 39.8M | 14.0M | 13.5M | 15.6M | 16.4M | |
Other Assets | 41.0M | 47.3M | 23.9M | 12.8M | 14.8M | 28.8M | |
Good Will | 72.4M | 71.2M | 84.0M | 71.3M | 194.9M | 98.1M | |
Property Plant Equipment | 62.7M | 63.6M | 59.3M | 58.2M | 67.0M | 43.5M | |
Net Tangible Assets | 202.3M | 212.3M | 213.0M | 218.2M | 250.9M | 234.7M | |
Retained Earnings Total Equity | 57.7M | 59.4M | 21M | 1.3M | 1.1M | 1.1M | |
Capital Surpluse | 271.0M | 292.3M | 314.0M | 335.0M | 385.2M | 280.6M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Orthofix Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Orthofix Medical's short interest history, or implied volatility extrapolated from Orthofix Medical options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orthofix Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Orthofix Stock analysis
When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Orthofix Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orthofix Medical. If investors know Orthofix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orthofix Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.36) | Revenue Per Share 20.414 | Quarterly Revenue Growth 0.077 | Return On Assets (0.03) | Return On Equity (0.20) |
The market value of Orthofix Medical is measured differently than its book value, which is the value of Orthofix that is recorded on the company's balance sheet. Investors also form their own opinion of Orthofix Medical's value that differs from its market value or its book value, called intrinsic value, which is Orthofix Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orthofix Medical's market value can be influenced by many factors that don't directly affect Orthofix Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orthofix Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Orthofix Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orthofix Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.